期刊文献+

拓扑异构酶Ⅱα在粤东地区乳腺癌中的表达及其临床意义 被引量:2

Expression and clinical significance of TopoⅡαin breast cancer in eastern Guangdong
下载PDF
导出
摘要 目的:探讨粤东地区乳腺癌中拓扑异构酶Ⅱα(TopoⅡα)的表达情况及其临床意义。方法:收集2015—2016年于汕头大学医学院附属肿瘤医院就诊的乳腺癌患者术后石蜡包埋组织424例,采用免疫组化方法检测乳腺癌组织中TopoⅡα的表达,分析其与临床病理特征的关系;利用Kaplan-Meier plotter分析TopoⅡα表达与乳腺癌患者预后的相关性。结果:免疫组化检测雌激素受体阴性、孕激素受体阴性及人类表皮生长因子受体2(HER2)阳性的乳腺癌患者的TopoⅡα分级更高(P<0.05);Ki-67指数、组织学级别与TopoⅡα分级呈正相关(P<0.001);HER2过表达型及三阴性乳腺癌TopoⅡα的Ⅱ~Ⅳ级比例更高(P<0.01);TopoⅡα与年龄、T分期、淋巴结是否转移无相关性(P>0.05);TopoⅡα表达越高,乳腺癌患者无复发生存率及总生存率越低。结论:粤东地区乳腺癌中,TopoⅡα的高表达与乳腺癌高增殖能力及高组织学级别呈正相关;TopoⅡα的高表达常提示不良预后。 Objective:To investigate the expression and clinical significance of TopoⅡαin breast cancer in eastern Guangdong.Methods:From 2015 to 2016,424 cases of breast cancer patients treated in the Affiliated Tumor Hospital of Shantou University Medical College were collected.The expression of TopoⅡαin breast cancer tissues was detected by immunohistochemistry,and the relationship between TopoⅡαand clinical pathological characteristics was analyzed.Kaplan-Meier plotter was used to analyze the correlation between TopoⅡαexpression and the prognosis of breast cancer patients.Results:Among the ER negative,PR negative and HER2 positive breast cancer patients,TopoⅡαgrade was higher(P<0.05);Ki-67 index and histological grade were positively correlated with TopoⅡαgrade(P<0.001);HER2 overexpression and three negative breast cancer TopoⅡαhave a higher proportion ofⅡ-Ⅳgrade(P<0.01);TopoⅡαhad no correlation with age,T stage and lymph node metastasis(P>0.05);The higher the expression of TopoⅡα,the lower the recurrence free survival rate and the overall survival rate of breast cancer patients.Conclusion:The high expression of TopoⅡαis positively correlated with the high proliferative ability and high histological grade of breast cancer in the east of Guangdong Province.
作者 刘丽娟 张永渠 张丽莹 魏晓龙 LIU Lijuan;ZHANG Yongqu;ZHANG Liying;WEI Xiaolong(Department of Breast Center,Cancer Hospital of Shantou University Medical College,Shantou 515041,China;Cancer Research Center,Medical College of Xiamen University,Xiamen 361102,China;Department of Pathology,Cancer Hospital of Shantou University Medical College,Shantou 515041,China)
出处 《汕头大学医学院学报》 2020年第2期83-86,90,共5页 Journal of Shantou University Medical College
基金 国家自然科学基金(81602345) 广东省医学科学技术研究基金(20161158506719) 汕头市科技计划医学科技人才培育项目(190917085269842)。
关键词 乳腺癌 拓扑异构酶Ⅱα 不良预后 breast cancer topoisomeraseⅡα poor prognosis
  • 相关文献

参考文献2

二级参考文献15

  • 1施为建 王渝芝 蒋凤莲 等.乳腺浸润性导管癌中多药耐药相关蛋白的表达情况.中国健康月刊,2011,30(8):15-15.
  • 2Park K, Kim J, Lim S, et al. Topoisomerase II-alpha ( to- poII) and HER2 amplification in breast cancers and re- sponse to preoperative doxorubicin chemotherapy [J]. Eu- ropean Journal of Cancer, 2003 (5) :631 - 634.
  • 3Andrea JE, Adachi K, Morgan AR. Fluorometric assays for DNA topoisomerases and topoisomerase-targeted drugs: quantitation of catalytic activity and DNA cleavage [J] . Molecular Pharmacology, 1991 ( 4 ) : 495 - 501.
  • 4Konecny GE, Unteh M. HER2 gene amplification and re- sponse to dose dense sequential epirubicin and paclitaxel as neoadjuvant therapy of primary breast cancer [J]. Breast Cancer Res Treat, 2006 ( 1 ) : 48.
  • 5Siddiqa A, Long LM, Li L, et al. Expression of HER-2 in MCF-7 breast cancer cells modulates anti-apoptotic pro- teins Survivin and Bcl-2 via the extracellular signal-related kinase (ERK) and phosphoinositide-3 kinase (PI3K) signalling pathways[J]. BMC Cancer, 2008(8) :129.
  • 6Di Leo A, Larsimont D, Gabcberg D, et al. HER-2 and topo-isomerase IIct as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide [J]. Ann Oncol, 2001(8) :1081 - 1089.
  • 7MacGrogan G, Rudolph P, De Mascarel I. DNA topoi- somerase II alpha expression and the response to primary chemotherapy in breast cancer [J]. British Journal of Cancer, 2003 (5) :666 - 671.
  • 8Tan I)S, Marchio C, Jones RL. Triple negative breast cancer: molecular profiling and prognostic impact in ad-juvant anthracycline-treated patients [J]. Breast Cancer Research and Treatment, 2008( 1 ) :27 -44.
  • 9潘亚奇,袁公,杨艳维.DNA拓扑异构酶Ⅱα与肿瘤[J].医学信息(中旬刊),2011,24(2):415-415. 被引量:4
  • 10王云翔,范宇,张勤,王彤,刘红.TopoⅡα蛋白在不同分子亚型乳腺癌中的表达及其预后价值[J].中国肿瘤临床,2012,29(7):382-387. 被引量:10

共引文献3

同被引文献11

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部